甲磺酰胺,N-(2-碘苯基)-置于n-Ethylpiperidine Hypophosphite,偶氮二异丁腈,Sodium Hydride体系中,用 N,N-二甲基甲酰胺,苯 用作溶剂,化学反应 5.25H,反应生成N-苯基甲磺酰胺 参考文献:A Radical Based Addition-elimination Route For The Preparation Of Indoles 标题:A Radical Based Addition-elimination Route For The Preparation Of Indoles 摘要:包括三环衍生物在内的吲哚,是通过将芳基自由基环化到乙烯基卤化物上,随后消除卤素自由基以及生成的产物的互变异构作用产生的;这些芳基自由基是通过"清洁方法学"生成的,或者是通过碘离子与芳二氮鎓盐的反应,或者是通过磷中心自由基与芳基碘的反应. Doi:10.1039/b002565H
专利信息
专利号:US-8901352-B2 优先权日:2011-01-13 标题 :Method for the synthesis of rasagiline 发明人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN 权利人:REIS ÖMER; KOYUNCU HASAN; ESIRINGU ILKER; SAHIN YASEMIN; GULCAN H OZAN; NOBEL ILAÇ SANAYII VE TICARET A S 摘要:We have developed a new method for the synthesis of Rasagiline (Formula 1) based on the alkylation of trifluoroacetyl protected aminoindan. This protection enabled us to carry out an alkylation of aminoindan with a high yield and purity under very mild conditions with a wide range of reaction conditions and reagent selection. Considering the ease, purity and high yields of introducing and removal of the trifluoroacetyl group, this approach is a highly practical and economical way for the synthesis of rasagiline or its pharmaceutically acceptable salts.
专利号:WO-9013609-A1 优先权日:1989-05-01 标题 :Novel fluorescent pigment compositions and a process for their preparation and use of same 发明人:MALLAVARAPU LEO X 权利人:MALLAVARAPU LEO X 摘要:A process is disclosed for producing novel fluorescent pigment compositions with no formaldehyde or para-formaldehyde during their synthesis. The synthesis of these compositions is, for example, achieved by using an in situ reaction of epoxy resins of preferably up to a molecular weight of 20,000 with a sulfonamide compound, e.g., toluene sulfonamide, in the presence of a Lewis acid catalyst, followed by, preferably, the further reaction with an isocyanate, e.g., aliphatic isocyanate and/or para-toluene sulfonyl isocyanate. During this reaction, a fluorescent dye is incorporated into the molten mass.
专利号:US-2004110228-A1 优先权日:2002-04-01 标 题:Combinatorial organic synthesis of unique biologically active compounds 发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M 摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.
专利号:US-5783577-A 优先权日:1995-09-15 标题 :Synthesis of quinazolinone libraries and derivatives thereof 发明人:HOUGHTEN RICHARD A; OSTRESH JOHN M 权利人:TREGA BIOSCIENCES INC 摘要:The present invention provides synthetic combinatorial libraries of organic compounds based on the quinazolinone ring.
专利号:US-8461298-B2 优先权日:2004-11-01 标 题:Compositions and methods for modification of biomolecules 发明人:BERTOZZI CAROLYN R; AGARD NICHOLAS J; PRESCHER JENNIFER A; BASKIN JEREMY MICHAEL 权利人:BERTOZZI CAROLYN R; AGARD NICHOLAS J; PRESCHER JENNIFER A; BASKIN JEREMY MICHAEL; UNIV CALIFORNIA 摘要:The present invention provides modified cycloalkyne compounds; and method of use of such compounds in modifying biomolecules. The present invention features a cycloaddition reaction that can be carried out under physiological conditions. In general, the invention involves reacting a modified cycloalkyne with an azide moiety on a target biomolecule, generating a covalently modified biomolecule. The selectivity of the reaction and its compatibility with aqueous environments provide for its application in vivo (e.g., on the cell surface or intracellularly) and in vitro (e.g., synthesis of peptides and other polymers, production of modified (e.g., labeled) amino acids).
专利号:WO-9710221-A1 优先权日:1995-09-15 标 题:Synthesis of quinazolinone libraries 发明人:HOUGHTEN RICHARD A; OSTRESH JOHN M 权利人:TORREY PINES INST 摘要:The present invention provides synthetic combinatorial libraries of organic compounds based on the quinazolinone ring.
摘要:Tong, M. L.; Kunz, K.; Jaschinski, M.; Holzschneider, K.; Celik, I. E.; Kirsch, S. F., Science of Synthesis Knowledge Updates, (2020) 2, 247. 参考文献:10.1007/s003920050283 摘要:Schulze-Bahr E, Wedekind H, Haverkamp W, Borggrefe M, Assmann G, Breithardt G, Funke H. The LQT syndromes – current status of molecular mechanisms. Clinical Research in Cardiology. 1999 Apr;88(4):245–54. doi: 10.1007/s003920050283. 参考文献:10.1023/a:1007743521932 摘要:Marschang H, Beyer T, Karolyi L, Kübler W, Brachmann J. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle. Cardiovasc Drugs Ther. 1998 Dec;12(6):573–83. doi: 10.1023/a:1007743521932. 参考文献:10.1007/bf02253566|10.1159/000025393 摘要:Lai L, Su M, Tseng Y, Lien W. Sensitivity of the Slow Component of the Delayed Rectifier Potassium Current (IKs) to Potassium Channel Blockers: Implications for Clinical Reverse Use-Dependent Effects. Journal of Biomedical Science. 1999 Jul 16;6(4):251–9. doi: 10.1159/000025393. 参考文献:10.1007/s00380-003-0750-8 摘要:Hiramatsu M, Wu LM, Hirano Y, Kawano S, Furukawa T, Hiraoka M. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline. Heart Vessels. 2004 May;19(3):137–43. doi: 10.1007/s00380-003-0750-8.